TME PHARMA N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2545 EUR | +3.88% |
|
+2.41% | +10.65% |
Chart calendar TME Pharma N.V.
909664b00d18add190056a7f53.-fvoWVJHL2QGQOjTnHSdRLh3tf8irdettcGwY7nwLyk.o6ijan9wZRNcD52n5E31MPkEhJlQ37b13LGJU9e8TGCmlKY8KCBiIE0khw~4e6b2f18397959eab75a9600e2ac08ce
Upcoming events on TME Pharma N.V.
Past events on TME Pharma N.V.
| 2024-04-25 12:00 pm | Q4 2023 Earnings Release |
| 2024-03-25 | Glioblastoma Development Summit |
| 2024-03-17 | Bio Europe Spring Conference |
| 2023-11-17 10:30 pm | Society for Neuro Oncology Meeting |
| 2023-10-27 12:00 pm | Q2 2023 Earnings Release |
| 2023-10-21 05:15 am | European Society for Medical Oncology Congress |
| 2023-06-29 07:30 am | Annual General Meeting |
| 2023-06-03 02:15 pm | American Society of Clinical Oncology Conference - abstract #2048 |
| 2023-06-01 | American Society of Clinical Oncology Conference |
| 2023-04-24 12:00 pm | Q4 2022 Earnings Release |
| 2023-01-30 07:30 am | Extraordinary Shareholders Meeting |
| 2022-11-22 12:00 pm | Investor Meeting - Key Opinion Leader |
| 2022-11-18 07:30 pm | Society for Neuro-Oncology Meeting - Abstract No: CTNI-67 |
| 2022-10-26 01:00 pm | Interim 2022 Earnings Release |
| 2022-10-23 | BIO Europe Conference |
| 2022-09-20 | Sachs Associates Biotech in Europe Forum |
| 2022-09-08 | ESMO Congress Conference |
| 2022-06-29 08:00 am | Annual General Meeting |
| 2022-06-10 08:00 am | Investor Meeting - Key Opinion Leader |
| 2022-06-02 | American Society of Clinical Oncology Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 6,60 - | 0,03 0,10 -66% |
|
EBITDA Million EUR | Released Forecast Spread | -3,90 -4,95 21.19% | 0,00 | -13,2 -5,20 -153.87% | -11,9 -16,3 26.77% |
|
EBIT Million EUR | Released Forecast Spread | -3,95 -5,05 21.82% | 0,00 | -13,3 -5,30 -150.32% | -12,0 -16,3 26.2% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
Net income Million EUR | Released Forecast Spread | -0,86 -5,50 84.35% | -10,4 | 0,00 0,00 - | 0,00 0,00 - |
|
EPS EUR | Released Forecast Spread | 0,00 0,00 - | -32,0 | 0,00 0,00 - | 0,00 0,00 - |
| Announcement Date | 22/04/20 | 28/04/21 | 22/04/22 | 24/04/23 |
More events
Past sector events for TME Pharma N.V.
| 2024-05-10 07:00 am | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:10 pm | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | OMNIAB, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- ALTME Stock
- Calendar TME Pharma N.V.